Literature DB >> 16901411

High-density lipoprotein: is it always atheroprotective?

Benjamin J Ansell1, Gregg C Fonarow, Alan M Fogelman.   

Abstract

High-density lipoproteins (HDLs) are appropriately recognized for their many atheroprotective functions, including reverse cholesterol transport, as well as antioxidant, anti-inflammatory, and antithrombotic effects. Furthermore, the inverse relationship between HDL cholesterol and atherosclerosis is well documented in many populations. However, there is an increasing body of evidence that there are circumstances in which HDL may not be protective, and may in fact paradoxically promote vascular inflammation and oxidation of low-density lipoproteins. Recent studies have provided insight as to specific chemical modifications and structural changes within HDL associated with this phenotype. The presence of proinflammatory HDL coincides with conditions associated with chronic systemic inflammation, including atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16901411     DOI: 10.1007/s11883-006-0038-4

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  49 in total

Review 1.  The role of high-density lipoproteins in oxidation and inflammation.

Authors:  B J Van Lenten; M Navab; D Shih; A M Fogelman; A J Lusis
Journal:  Trends Cardiovasc Med       Date:  2001 Apr-May       Impact factor: 6.677

Review 2.  High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions.

Authors:  Philip Barter; John Kastelein; Alistair Nunn; Richard Hobbs
Journal:  Atherosclerosis       Date:  2003-06       Impact factor: 5.162

3.  A normotriglyceridemic, low HDL-cholesterol phenotype is characterised by elevated oxidative stress and HDL particles with attenuated antioxidative activity.

Authors:  Anatol Kontush; Eliana Cotta de Faria; Sandrine Chantepie; M John Chapman
Journal:  Atherosclerosis       Date:  2005-03-28       Impact factor: 5.162

Review 4.  Emerging therapies targeting high-density lipoprotein metabolism and reverse cholesterol transport.

Authors:  Danielle Duffy; Daniel J Rader
Journal:  Circulation       Date:  2006-02-28       Impact factor: 29.690

5.  Cardiovascular status of carriers of the apolipoprotein A-I(Milano) mutant: the Limone sul Garda study.

Authors:  C R Sirtori; L Calabresi; G Franceschini; D Baldassarre; M Amato; J Johansson; M Salvetti; C Monteduro; R Zulli; M L Muiesan; E Agabiti-Rosei
Journal:  Circulation       Date:  2001-04-17       Impact factor: 29.690

6.  Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures.

Authors:  B J Van Lenten; S Y Hama; F C de Beer; D M Stafforini; T M McIntyre; S M Prescott; B N La Du; A M Fogelman; M Navab
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

7.  Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.

Authors:  Vicent Ribas; José Luis Sánchez-Quesada; Rosa Antón; Mercedes Camacho; Josep Julve; Joan Carles Escolà-Gil; Luís Vila; Jordi Ordóñez-Llanos; Francisco Blanco-Vaca
Journal:  Circ Res       Date:  2004-09-23       Impact factor: 17.367

8.  Smoking prevents the intravascular remodeling of high-density lipoprotein particles: implications for reverse cholesterol transport.

Authors:  Agueda C M Zaratin; Eder C R Quintão; Andrei C Sposito; Valéria S Nunes; Ana Maria Lottenberg; Richard E Morton; Eliana C de Faria
Journal:  Metabolism       Date:  2004-07       Impact factor: 8.694

9.  Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity.

Authors:  Boris Hansel; Philippe Giral; Estelle Nobecourt; Sandrine Chantepie; Eric Bruckert; M John Chapman; Anatol Kontush
Journal:  J Clin Endocrinol Metab       Date:  2004-10       Impact factor: 5.958

10.  Elevated HDL cholesterol is functionally ineffective in cardiac transplant recipients: evidence for impaired reverse cholesterol transport.

Authors:  Dmitri Sviridov; Jaye Chin-Dusting; Paul Nestel; Bronwyn Kingwell; Anh Hoang; Beata Olchawa; Jennifer Starr; Anthony Dart
Journal:  Transplantation       Date:  2006-02-15       Impact factor: 4.939

View more
  26 in total

1.  Cardiovascular risk reduction via increasing HDL cholesterol: the promise of the dal-OUTCOMES Trial.

Authors:  Kyaw Soe; Anis Alam; Charles Philip; Edison Ruiz; Keshwar Ramkissoon; Samy I McFarlane
Journal:  Curr Diab Rep       Date:  2011-02       Impact factor: 4.810

2.  HDL (High-Density Lipoprotein) Metrics and Atherosclerotic Risk in Women.

Authors:  Samar R El Khoudary; Indre Ceponiene; Saad Samargandy; James H Stein; Dong Li; Matthew C Tattersall; Matthew J Budoff
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-09       Impact factor: 8.311

3.  Increased high-density lipoprotein cholesterol is associated with a high prevalence of pre-hypertension and hypertension in community-dwelling persons.

Authors:  Ryuichi Kawamoto; Yasuharu Tabara; Katsuhiko Kohara; Tetsuro Miki; Masanori Abe; Tomo Kusunoki
Journal:  Endocrine       Date:  2012-03-14       Impact factor: 3.633

4.  Increase HDL-C level over the menopausal transition is associated with greater atherosclerotic progression.

Authors:  Samar R El Khoudary; Lin Wang; Maria M Brooks; Rebecca C Thurston; Carol A Derby; Karen A Matthews
Journal:  J Clin Lipidol       Date:  2016-04-26       Impact factor: 4.766

5.  Coronary artery diseases in South Asian immigrants: an update on high density lipoprotein role in disease prevention.

Authors:  Sunita Dodani
Journal:  J Immigr Minor Health       Date:  2008-09-24

6.  Atherothrombosis in South asians: implications of atherosclerotic and inflammatory markers.

Authors:  Sunita Dodani
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

7.  C-reactive protein and lipid parameters in older persons aged 80 years and older.

Authors:  M Cesari; G Onder; V Zamboni; E Capoluongo; A Russo; R Bernabei; M Pahor; F Landi
Journal:  J Nutr Health Aging       Date:  2009-08       Impact factor: 4.075

8.  Interaction of HDL cholesterol concentrations on the relationship between physical function and inflammation in community-dwelling older persons.

Authors:  Matteo Cesari; Emanuele Marzetti; Alice Laudisio; Livia Antonica; Marco Pahor; Roberto Bernabei; Giuseppe Zuccalà
Journal:  Age Ageing       Date:  2009-11-05       Impact factor: 10.668

9.  Serum amyloid A impairs the antiinflammatory properties of HDL.

Authors:  Chang Yeop Han; Chongren Tang; Myriam E Guevara; Hao Wei; Tomasz Wietecha; Baohai Shao; Savitha Subramanian; Mohamed Omer; Shari Wang; Kevin D O'Brien; Santica M Marcovina; Thomas N Wight; Tomas Vaisar; Maria C de Beer; Frederick C de Beer; William R Osborne; Keith B Elkon; Alan Chait
Journal:  J Clin Invest       Date:  2015-12-07       Impact factor: 14.808

Review 10.  Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis.

Authors:  Matthias Briel; Ignacio Ferreira-Gonzalez; John J You; Paul J Karanicolas; Elie A Akl; Ping Wu; Boris Blechacz; Dirk Bassler; Xinge Wei; Asheer Sharman; Irene Whitt; Suzana Alves da Silva; Zahira Khalid; Alain J Nordmann; Qi Zhou; Stephen D Walter; Noah Vale; Neera Bhatnagar; Christopher O'Regan; Edward J Mills; Heiner C Bucher; Victor M Montori; Gordon H Guyatt
Journal:  BMJ       Date:  2009-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.